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Abstract
Background: Chronic cigarette smoke exposure is known to activate the adaptive immune system; however, the
functional role of these processes is currently unknown. Given the role of oxidized lipids in driving innate
inflammatory responses to cigarette smoke, we investigated whether an adaptive immune response against
damaged lipids was induced following chronic cigarette smoke exposure.
Methods and results: Using a well-established mouse model, we showed that cigarette smoke exposure led to a
progressive increase in pulmonary antibodies against oxidized low-density lipoprotein (OxLDL). Functionally, we
found that intranasal delivery of an antibody against oxidized phosphatidylcholine (anti-OxPC; clone E06) increased
lipid and particle uptake by pulmonary macrophages without exacerbating cigarette smoke-induced neutrophilia.
We also found that anti-OxPC treatment increased particle uptake following smoking cessation. Finally, the frequency
of pulmonary macrophages with internalized particles was increased after prolonged smoke exposure, at which time
lung anti-OxPC responses were highest.
Conclusions: Altogether, this is the first report to demonstrate a non-pathogenic, and possibly protective, function of a
newly identified autoantibody induced by chronic cigarette smoke exposure.
Background
Cigarette smoking is a complex pulmonary insult caus-
ing chronic lung inflammation and lung degenerative
diseases such as chronic obstructive pulmonary disease
(COPD). A hallmark of advanced COPD, and mice
chronically exposed to cigarette smoke, is the formation
of tertiary lymphoid tissues (TLTs) in the lungs. These
immune structures consist of B and T cells, as well as
dendritic cells and macrophages [1–3]. The development
of TLTs within the lungs suggests local activation of
adaptive immune processes that may generate effector T
cells as well as antibody production [4]. In fact, signs of
T cell clonal expansion and autoantibody production
within the lungs have been identified in humans and
animal models [3, 5–9]. However, the role of these adap-
tive immune processes has yet to be fully understood.
We recently reported that damaged pulmonary lipids
play an important role in triggering innate inflammatory
responses elicited by cigarette smoke [10]. Characteristic
features of cigarette smoke exposure, such as lipid accu-
mulation in macrophages, IL-1α and GM-CSF produc-
tion, and neutrophil recruitment were recapitulated by
delivery of damaged lipids to the lungs [10]. The role of
oxidized lipids in inducing inflammatory processes and
the accumulation of lipid-laden macrophages are key
features shared with atherosclerosis [11–14]. With re-
gard to the adaptive immune system, atherosclerosis is
associated with an increase in antibodies against oxi-
dized low-density lipoprotein (OxLDL), largely recogniz-
ing the oxidized phospholipid fraction of the
macromolecules [15]. Current evidence suggests that
these anti-OxLDL antibodies appear to have detrimental
as well as beneficial effects on disease pathogenesis
[12–15]. As both smoking-induced lung injury and
atherosclerosis are driven, in part, by chronic damage
to lipids, it is plausible that prolonged cigarette smoke
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exposure similarly triggers an adaptive response towards
oxidized lipids.
We therefore hypothesized that chronic cigarette
smoke exposure leads to the production of antibodies
against oxidized lipids, and that these antibodies may
contribute to limit the magnitude of the response to-
wards damaged pulmonary lipids. To test this hypoth-
esis, we used a well-characterized mouse model of
cigarette smoke exposure characterized by rapid and
persistent activation of innate immune processes,
followed by induction of adaptive immune responses
[10, 16, 17]. We found that chronic exposure to cigarette
smoke led to the induction of antibodies against oxi-
dized LDL in the lungs. Moreover, delivery of a mouse
monoclonal antibody against oxidized phosphatidylcho-
line (OxPC) during acute smoke exposure reduced some
inflammatory markers, and increased lipid and particle
uptake by pulmonary macrophages. Altogether, this is
the first report to document the presence of antibodies
against oxidized LDL following chronic smoke exposure
and its link to a non-pathogenic, and possibly protective,
function in the lungs.
Methods
Cigarette smoke exposure and interventions
Six to 8 week old female C57BL/6, BALB/c, and A/J
mice were exposed to cigarette smoke using a well-
characterized whole-body exposure system for 1 h, twice
a day, 5 days per week for up to 24 weeks [10, 16, 17].
Control groups were exposed to room air. The Animal
Research Ethics Board of McMaster University approved
all experimental procedures (Animal Utilization Protocol
07-09-57).
A monoclonal IgM antibody against oxidized phosphat-
idylcholine (clone E06, Avanti Polar Lipids, Alabaster, AL,
USA) or a mouse IgM isotype control (clone MM-30, Bio-
legend, San Diego, CA, USA), was delivered intranasally
(20 μg in 35 μl of sterile PBS) every day 1 h prior to the
first cigarette smoke exposure, or at a similar time
for cessation experiments.
Assessment of bronchoalveolar lavage cells and
mediators
Mice were anesthetized with isoflurane and euthanized
by exsanguination. Lungs were removed from the chest
cavity and the trachea canulated. Bronchoalveolar lavage
(BAL) was performed by lavaging the lungs twice with
500 μl of sterile cold PBS. Total cell concentration was
determined using a hemacytometer. The BAL was then
centrifuged at 800 g for 8 min. Cytospins were prepared
from the resuspended cell pellet and the differential
counts performed by counting at least 300 cells per
cytospin. Levels of monocyte chemoattractant protein-1
(MCP-1), granulocyte-macrophage colony-stimulating
factor (GM-CSF), and interleukin 1 alpha (IL-1α) were
measured in the BAL fluid by ELISA according to the
manufacturers’ instructions (MCP-1 and IL-1 α: R&D
Biosystems, Minneapolis, MN, USA; GM-CSF:
eBioscience Inc., San Diego, CA, USA).
Measurement of antibodies with affinity for oxidized LDL
Antibodies against oxidized LDL (OxLDL) were mea-
sured in the mouse BAL fluid. Nunc-immuno Multisorp
plates were coated overnight at 4 °C with 2 μg of human
OxLDL (AlfaAesar, Heysham, UK) per well in 100 μl of
PBS. Wells were washed 3 times with PBS-T and then
blocked with PBS-T-BSA (PBS; 0.05 % Tween 20; 5 %
bovine serum albumin) for 1 h at room temperature.
Samples diluted in PBS-T-1 % BSA were incubated for
2 h at room temperature on an orbital plate shaker at
550 rpm. Wells were washed four times with PBS-T. For
total anti-OxLDL assessment, wells were incubated with
a rabbit anti-mouse Ig (H + L chains) coupled to HRP
(Sigma-Aldrich Canada, Oakville, ON, Canada) for 1 h.
For isotype-specific assessment, wells were incubated
with a biotinylated rabbit anti-mouse IgM, a biotinylated
rabbit anti-mouse IgA, or a rabbit anti-mouse IgG for
1 h, followed by a 30-minute incubation with
streptavidin-HRP (Sigma-Aldrich Canada, Oakville, ON,
Canada). HRP substrate was used and the absorbance at
550 nm measured (Bio-Rad, Hercules, CA, USA).
Assessment of pulmonary macrophage size, intracellular
lipids, and particle content
Pulmonary macrophage size and intracellular lipids were
assessed as previously described using BAL cytospins
[10]. Particle inclusions in macrophages were also
assessed using BAL cytospins. Black carbon-like inclu-
sions were counted in 300 to 400 macrophages/mouse.
Data are expressed as percentage of macrophages with 0,
1–4, and ≥5 particle inclusions, or as the absolute
number of particle-containing macrophages (see figure
legends for details).
Statistical analysis
Statistical differences were assessed using unpaired Stu-
dent’s t-test (2 groups) or one-way ANOVA (>2 groups)
followed by a post-hoc comparison of every group using
a Bonferroni correction for multiple comparisons. Tests
were performed using GraphPad Prism.
Results
Chronic cigarette smoke exposure induces pulmonary
antibodies against oxidized LDL
To investigate whether persistent cigarette smoke expos-
ure elicits antibody responses against oxidized lipids, we
exposed BALB/c mice to cigarette smoke for 4 days,
8 weeks, and 24 weeks. Anti-OxLDL antibodies were
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assessed by ELISA in the bronchoalveolar lavage fluid
(BALF) and the serum. As controls, we included age-
matched, room air-exposed mice in the analysis. We
found that BALF levels of anti-OxLDL antibodies in-
creased over time to reach levels 6-fold higher than
room air controls after 8 and 24 weeks of cigarette
smoke exposure (\). Elevated levels of anti-OxLDL anti-
bodies were also observed in C57BL/6 and A/J mice
exposed for 24 weeks to cigarette smoke (Fig. 1b-c).
Similar to our observations with anti-nuclear autoanti-
bodies, we observed a more robust increase in BALB/c
than in C57BL/6 mice [3]. Of note, we did not observe
increased levels of anti-OxLDL antibodies in the serum
of cigarette smoke-exposed mice at any of the time
points included in the analysis (data not shown). Isotype
analyses in BALB/c mice revealed marked increases in
IgM and IgA anti-OxLDL antibodies following exposure
to cigarette smoke for 24 weeks, with only a small in-
crease in IgG (Fig. 1d). These data show for the first
time that cigarette smoke exposure elicits antibodies
against oxidized lipids.
Antibodies against oxidized phosphatidylcholine do not
exacerbate cigarette smoke-induced lung inflammation
Since cigarette smoke exposure elicited the production
of antibodies against oxidized phospholipids, we next in-
vestigated whether these antibodies impact smoke-
induced inflammatory processes, favoring a short-term
exposure protocol to minimize the amount of endogen-
ously produced anti-OxLDL antibodies in cigarette
smoke-exposed mice. To this end, we exposed mice to
cigarette smoke for 4 days and administered daily a
monoclonal antibody against oxidized phosphatidylcho-
line (OxPC), the most prevalent phospholipid in lung
surfactant. We found that the anti-OxPC had no effect
on the cellular response to smoke exposure when com-
pared to isotype control (Fig. 2b). Both isotype and anti-
OxPC antibodies lead to an increase in mononuclear
cells (Fig. 2b). Interestingly, IL-1α, a key mediator in
the pulmonary response to cigarette smoke exposure
[10, 18], was significantly reduced in the anti-OxPC-
treated compared to the isotype control group. In con-
trast, MCP-1 and GM-CSF levels were similar between
the two experimental groups (Fig. 2c). Altogether, these
data suggest that antibodies against OxPC do not exacer-
bate cigarette smoke-induced inflammatory processes.
Antibodies against oxidized phosphatidylcholine promote
lipid and particle uptake by pulmonary macrophages
Pulmonary macrophages are key orchestrators of the pul-
monary response to cigarette smoke exposure [10, 19].
We therefore investigated the effect of anti-OxPC anti-
body delivery during smoke exposure on pulmonary mac-
rophages. We observed that anti-OxPC delivery led to an
increase in the size of pulmonary macrophages, which ap-
peared to be largely driven by an increased accumulation
Fig. 1 Cigarette smoke exposure leads to an increase in pulmonary antibodies with affinity for oxidized LDL. Female 6–8 week old mice were
exposed to room air (RA) or cigarette smoke (CS) for 1 h, twice a day, 5 days a week for 4 days, 8 weeks, or 24 weeks. Levels of total
immunoglobulins with affinity for oxidized low-density lipoprotein (OxLDL) were measured by direct ELISA in the bronchoalveolar lavage
fluid (BALF) of a BALB/c, b C57BL/6, and c A/J mice. d Isotypes were measured by ELISA in the BALF of BALB/c mice exposed for
24 weeks to RA or CS using isotype specific secondary antibodies. Data represent mean ± SEM; n = 4–5/group; *p < 0.05; ***p < 0.001
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of intracellular lipid droplets (Fig. 3a-b). We also noticed
that anti-OxPC treatment markedly increased the uptake
of black carbon-like particles, likely particles contained
within cigarette smoke (Fig. 3c-d). These data suggest that
antibodies against OxPC have the ability to increase lipid
uptake by macrophages and facilitate the internalization
of cigarette smoke particles.
Antibodies against oxidized phosphatidylcholine promote
particle uptake following cessation of cigarette smoke
exposure
When delivered daily during a short-term cigarette
smoke exposure protocol, the anti-OxPC antibody
caused smoke particles to be internalized by pulmonary
macrophages. As particles can remain trapped in the
lungs for years after smoking cessation, we sought to in-
vestigate if administration of the anti-OxPC antibody
after smoking cessation could facilitate the internaliza-
tion of particles trapped in the lungs. Mice were exposed
to cigarette smoke for 8 weeks and, following two days
of smoking cessation, received anti-OxPC or isotype
control antibodies intranasally for 3 consecutive days
(Fig. 4a). Anti-OxPC antibody delivery markedly
increased the number of internalized smoke particles in
alveolar macrophages (Fig. 4b-c). This suggests that the
anti-OxPC antibodies have the ability to promote the
uptake of particles within the lung by pulmonary macro-
phages following smoking cessation.
Particle uptake by pulmonary macrophages increases
over the course of exposure to cigarette smoke
As anti-OxPC antibodies promote particle uptake, we
sought to investigate if the frequency of macrophages
with internalized particles increased over time, mirroring
the humoral response to oxidized lipids in cigarette
smoke-exposed mice. We found that the number of
mononuclear cells in the BAL increased with the dur-
ation of cigarette smoke exposure (Fig. 5a). The number
of pulmonary macrophages with internalized particles
only increased above baseline after 24 weeks of cigarette
smoke exposure and remained elevated following smok-
ing cessation (Fig. 5b). These observations suggest that
Fig. 2 Impact of anti-OxPL antibody delivery on CS-induced pulmonary inflammation. a Female 6–8 week old C57BL/6 mice were exposed to
room air (RA) or cigarette smoke (CS) for 1 h, twice a day for 4 days. They received phosphate-buffered solution (35 μl; PBS), a mouse IgM isotype
control (20 μg in 35 μl; ISO), or a mouse monoclonal antibody against oxidized phosphadytilcholine (20 μg in 35 μl; clone E06) intranasally every
day before the first cigarette smoke exposure of the day. b Total cells, mononuclear cells and neutrophils were counted in the bronchoalveolar
lavage (BAL). c Monocyte chemotactic protein 1 (MCP-1), interleukin-1 alpha (IL-1α), and granulocyte macrophage colony-stimulating factor
(GM-CSF) levels were measure in the BAL fluid (BALF) by ELISA. Data represent mean ± SEM; n = 4–5/group; representative of two independent
experiments; bars with different superscripts are significantly different from each other
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particles accumulate in macrophages over a prolonged
period of smoke exposure or, alternatively, that anti-
bodies against oxidized lipids contribute to increase par-
ticle uptake at these time points.
Discussion
We previously showed that cigarette smoke exposure
disrupts pulmonary lipid homeostasis [10], leading to
innate immune activation. In the present study, we in-
vestigated whether persistent innate immune activation
induces humoral immune responses against oxidized
lipids, and the consequences of these antibody responses
to cigarette smoke-induced inflammatory processes.
Using a well-characterized pre-clinical model of
cigarette smoke exposure [3, 10], we investigated the
levels of antibodies against oxidized lipids in the bron-
choalveolar lavage and serum of mice exposed to
cigarette smoke. Antibodies were measured by ELISA,
using plates coated with OxLDL, a rich source of oxi-
dized lipids. We observed a time-dependent increase in
anti-OxLDL antibody levels in the BAL of BALB/c mice
with a small, albeit, statistically significant increase after
4 days of smoke exposure. The increase was most pro-
nounced after 8 and 24 weeks. Of note, anti-OxLDL
antibodies were increased in the lungs but not the
serum. This observation is in agreement with previous
reports from our laboratory, documenting local produc-
tion of anti-nuclear antibodies following cigarette smoke
exposure for 8 and 24 weeks [3] and suggests that anti-
bodies were likely produced locally. It is possible that
the induction of autoantibodies in response to cigarette
smoke exposure, including anti-OxLDL and anti-nuclear
antigen antibodies [3], are part of a response aimed at
clearing pro-inflammatory damage-associated molecular
patterns in the lungs.
The origin of anti-OxLDL antibodies after 4 days of
smoke exposure is currently not understood, as de novo
induction of B cell responses takes several days. Anti-
OxLDL antibodies are naturally found in the circulation,
even under homeostatic conditions, and have been
shown to aid in the clearance of apoptotic cells and bac-
terial agents [20, 21]. Hence, it is possible that the early
increase in anti-OxLDL antibodies after 4 days of smoke
exposure is secondary to smoke-induced vascular
Fig. 3 Anti-OxPL antibodies increase lipid and smoke particle uptake by pulmonary macrophages. Female 6–8 week old C57BL/6 mice were
exposed to room air (RA) or cigarette smoke (CS) for 1 h, twice a day for 4 days. They received phosphate-buffered solution (35 μl; PBS), a mouse
IgM isotype control (20 μg in 35 μl; ISO), or a mouse monoclonal antibody against oxidized phosphatidylcholine (20 μg in 35 μl; clone E06) intranasally
each day before the first cigarette smoke exposure of the day. Bronchoalveolar lavage (BAL) cytospins were used to assess a the size of pulmonary
macrophages and b were also stained with the lipophilic dye BODIPY to detect intracellular lipid accumulation in macrophages. c Black particles were
counted in pulmonary macrophages and expressed as the absolute number of macrophages with no (white), 1–4 (grey) or >5 (black)
intracellular particles. d Representative BAL cells cytospins of cigarette smoke-exposed and PBS or anti-OxPC (E06)-treated animals with
arrows showing macrophages with internalized smoke particles. Data represent mean ± SEM; n = 4/group; representative of two independent
experiments. Bars with different superscripts are significantly different from each other
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leakage and reflects a non-specific increase in serum
antibodies in the lungs. Alternatively, germline-encoded
natural antibodies produced by B1 cells target a diverse
range of antigens and, although the spontaneous produc-
tion of natural antibodies remains poorly understood,
specific idiotypes have been shown to be increased in
the context of infection or chronic disease [20, 22, 23].
Thus, it is possible that acute exposure to cigarette
smoke induces B cells within the lung to release anti-
bodies with specificity for OxLDL as part of an innate
inflammatory response independent of TLT formation.
Further research is required to determine the precise
origin of the anti-OxLDL antibodies observed in our
model.
The predominant isotypes of anti-OxLDL measured in
the BAL were IgM and IgA. IgA is a defining feature of
mucosal B cell responses, suggesting that chronic expos-
ure to cigarette smoke induced a lung-specific humoral
response. Moreover, we reported a similar pattern with
anti-nuclear antibodies (ANA) in cigarette smoke-
Fig. 4 Anti-OxPL antibodies increase smoke particle uptake by pulmonary macrophages when delivered during smoking cessation. a 6–8 week
old female C57BL/6 mice were exposed to room air (RA) or cigarette smoke (CS) for 1 h, twice a day, 5 days a week for 8 weeks. They were then
subjected to 2 days of complete smoking cessation and, on the morning of the following 3 consecutive days, received phosphate-buffered solution
(35 μl; PBS), a mouse IgM isotype control (20 μg in 35 μl; ISO), or a mouse monoclonal antibody against oxidized phosphadytilcholine (20 μg in 35 μl;
clone E06) intranasally. b Black smoke particles were counted in pulmonary macrophages and expressed as the absolute number of macrophages with
no (white), 1–4 (grey) or >5 (black) intracellular particles. c A representative cytospin from cigarette smoke-exposed mice that received the E06 antibody
during cessation
Fig. 5 The proportion of pulmonary macrophages with intracellular particles increases over the course of cigarette smoke exposure. Female 6–8
week old BALB/c mice were exposed to room air (RA) or cigarette smoke (CS) for 1 h, twice a day, 5 days a week for 4 days, 8 weeks, or 24 weeks, and
followed by cessation periods. a Lungs were subjected to bronchoalveolar lavage (BAL), total cells counted, and cell differentials performed to
determined the absolute number of mononuclear cells in the BAL. b Black particles were counted in pulmonary macrophages and expressed as the
absolute number of macrophages with intracellular particles. The dashed red line represents the highest number of pulmonary macrophage with
internalized particles observed in a room air exposed mouse (particle background). Data represent mean ± SEM; n = 4–5/group; *p < 0.05
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exposed mice, which also showed a time dependent
induction with a preferential increase in IgM and IgA
isotypes [3].
Functionally, anti-OxPC antibodies significantly in-
creased lipid and particle uptake by pulmonary macro-
phages. Phospholipids are abundant in the pulmonary
surfactant, and in the context of cigarette smoke expos-
ure these lipids are prone to be oxidized. The observed
increased lipid uptake by pulmonary macrophages may
be the result of antibody-mediated aggregation of dam-
aged lipids. Similarly, smoke particles can interact with
and get trapped in the pulmonary surfactant [24, 25].
Anti-OxPC antibodies may aggregate smoke particles
coated with oxidized surfactant, thus facilitating their
uptake by macrophages. Interestingly, the particle uptake
was observed following smoking cessation suggesting
that anti-OxPC antibody-mediated uptake does not
require active smoking, and can likely facilitate the
elimination of previously trapped smoke particles.
These findings are similar to what we observed fol-
lowing prolonged smoke exposure where increased
levels of anti-OxLDL antibodies are associated with
increased numbers of particle-containing macro-
phages. These antibodies could therefore help in the
clearance of smoke particles by pulmonary macro-
phages, and appear to play a protective role. This
may provide an opportunity to develop therapeutic
strategies to clear particles trapped in the lung;
however, further research is required to show this
conclusively.
Increased lipid and particle uptake by anti-OxPC anti-
bodies did not exacerbate the inflammatory processes in
cigarette smoke-exposed mice. Despite an increase in
mononuclear cells, which was also observed in the
isotype-treated group, no further increase in neutrophils
was observed. Moreover, we observed decreased levels
of IL-1α, a critical mediator of cigarette smoke-induced
inflammation, in the anti-OxPC-treated group. There-
fore, these antibodies could help clear damaged lipids
and smoke particles from the lungs without aggravating
the inflammatory response. Of note, damaged or oxi-
dized lipids, and smoke particles are potentially more
damaging or pro-inflammatory when left in the extracel-
lular milieu than when internalized. Oxidation of phos-
pholipids can lead to the enzymatic release of lipid
species with ‘platelet-activating factor’ (PAF)-like activity
and lysophospholipids that have well-documented pro-
inflammatory effects [26–28]. Smoke particles can also
contain heavy metals such as iron, which catalyze the
generation of ‘reactive oxygen species’ (ROS) through
the Fenton reaction [29]. Further investigation is re-
quired to fully understand the mechanisms by which
anti-OxPC antibodies alter the pulmonary inflammatory
response to cigarette smoke.
Conclusions
While markers of B cell activation are increased in
COPD/emphysema, as well as in mice chronically ex-
posed to cigarette smoke [1–3, 30, 31], the role of B cells
in the pathogenesis of COPD remains poorly under-
stood. Whether these B cell-mediated responses are
beneficial or detrimental will likely depend on antigen
specificity as well as isotype. This study describes for the
first time the pulmonary humoral response to oxidized
lipids induced by cigarette smoke exposure. It also pro-
vides insight into the potential role of these antibodies
in the general pulmonary response to cigarette smoke.
Additional investigations will be necessary to fully appre-
ciate the role of the humoral response to damaged lipids
in the context of cigarette smoke exposure, and its
potential as a therapeutic tool.
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